162 related articles for article (PubMed ID: 16900752)
1. Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter.
Haddock G; Cross AK; Plumb J; Surr J; Buttle DJ; Bunning RA; Woodroofe MN
Mult Scler; 2006 Aug; 12(4):386-96. PubMed ID: 16900752
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS-1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes.
Cross AK; Haddock G; Stock CJ; Allan S; Surr J; Bunning RA; Buttle DJ; Woodroofe MN
Brain Res; 2006 May; 1088(1):19-30. PubMed ID: 16630594
[TBL] [Abstract][Full Text] [Related]
3. The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
Cross NA; Chandrasekharan S; Jokonya N; Fowles A; Hamdy FC; Buttle DJ; Eaton CL
Prostate; 2005 May; 63(3):269-75. PubMed ID: 15599946
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of ADAMTS-1, -4, -5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis.
Cross AK; Haddock G; Surr J; Plumb J; Bunning RA; Buttle DJ; Woodroofe MN
J Autoimmun; 2006 Feb; 26(1):16-23. PubMed ID: 16303287
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes in expression of tissue inhibitor of metalloproteinases-3 associated with transition from the notochordal nucleus pulposus to the fibrocartilaginous nucleus pulposus in rabbit intervertebral disc.
Tsuji T; Chiba K; Imabayashi H; Fujita Y; Hosogane N; Okada Y; Toyama Y
Spine (Phila Pa 1976); 2007 Apr; 32(8):849-56. PubMed ID: 17426628
[TBL] [Abstract][Full Text] [Related]
6. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
Troeberg L; Fushimi K; Scilabra SD; Nakamura H; Dive V; Thøgersen IB; Enghild JJ; Nagase H
Matrix Biol; 2009 Oct; 28(8):463-9. PubMed ID: 19643179
[TBL] [Abstract][Full Text] [Related]
7. The regulation of aggrecanase ADAMTS-4 expression in human Achilles tendon and tendon-derived cells.
Corps AN; Jones GC; Harrall RL; Curry VA; Hazleman BL; Riley GP
Matrix Biol; 2008 Jun; 27(5):393-401. PubMed ID: 18387286
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of ADAMTS-1, -4, and -5 in the trabecular meshwork.
Keller KE; Bradley JM; Acott TS
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5769-77. PubMed ID: 19553617
[TBL] [Abstract][Full Text] [Related]
9. Human glioblastomas overexpress ADAMTS-5 that degrades brevican.
Nakada M; Miyamori H; Kita D; Takahashi T; Yamashita J; Sato H; Miura R; Yamaguchi Y; Okada Y
Acta Neuropathol; 2005 Sep; 110(3):239-46. PubMed ID: 16133547
[TBL] [Abstract][Full Text] [Related]
10. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of ADAM-17 expression in active lesions in multiple sclerosis.
Plumb J; McQuaid S; Cross AK; Surr J; Haddock G; Bunning RA; Woodroofe MN
Mult Scler; 2006 Aug; 12(4):375-85. PubMed ID: 16900751
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
Sawaji Y; Hynes J; Vincent T; Saklatvala J
Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
[TBL] [Abstract][Full Text] [Related]
13. Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
Lim NH; Kashiwagi M; Visse R; Jones J; Enghild JJ; Brew K; Nagase H
Biochem J; 2010 Oct; 431(1):113-22. PubMed ID: 20645923
[TBL] [Abstract][Full Text] [Related]
14. Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease ADAMTS-5 expression in interleukin 1 beta-treated chondrocytes.
Tahiri K; Korwin-Zmijowska C; Richette P; Héraud F; Chevalier X; Savouret JF; Corvol MT
Ann Rheum Dis; 2008 May; 67(5):696-702. PubMed ID: 17901089
[TBL] [Abstract][Full Text] [Related]
15. Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration.
Pockert AJ; Richardson SM; Le Maitre CL; Lyon M; Deakin JA; Buttle DJ; Freemont AJ; Hoyland JA
Arthritis Rheum; 2009 Feb; 60(2):482-91. PubMed ID: 19180493
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS proteoglycanases in the physiological and pathological central nervous system.
Lemarchant S; Pruvost M; Montaner J; Emery E; Vivien D; Kanninen K; Koistinaho J
J Neuroinflammation; 2013 Oct; 10():133. PubMed ID: 24176075
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Mimata Y; Kamataki A; Oikawa S; Murakami K; Uzuki M; Shimamura T; Sawai T
Int J Rheum Dis; 2012 Feb; 15(1):36-44. PubMed ID: 22324945
[TBL] [Abstract][Full Text] [Related]
18. [Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis].
Ji Q; Zhang Q; Wang Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1080-4. PubMed ID: 24279019
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury.
Demircan K; Topcu V; Takigawa T; Akyol S; Yonezawa T; Ozturk G; Ugurcu V; Hasgul R; Yigitoglu MR; Akyol O; McCulloch DR; Hirohata S
Biomed Res Int; 2014; 2014():693746. PubMed ID: 25101296
[TBL] [Abstract][Full Text] [Related]
20. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts.
Mladenovic Z; Saurel AS; Berenbaum F; Jacques C
J Rheumatol; 2014 May; 41(5):945-54. PubMed ID: 24737908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
